Look for:

Our offer for

GILEAD SCIENCES INC.


ISIN:
US3755581036
WKN:
375558103

2023/09/22 12:47:41
Price
70.88 EUR
Difference -0.28% (-0.20)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)87,976 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)70.70 EUR (102)
Ask (Ask size)70.86 EUR (45)
Open70.70 EUR
High70.88 EUR
Low70.70 EUR
Close (prev. day)71.08 EUR
VWAP70.82973 EUR
Volume (pcs)74
Trading volume5,241.40
Number of trades6
Last size1

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/09/22 12:47:41
Price
70.88 EUR
Difference -0.28% (-0.20)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)87,976 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)70.70 EUR (102)
Ask (Ask size)70.86 EUR (45)
Open70.70 EUR
High70.88 EUR
Low70.70 EUR
Close (prev. day)71.08 EUR
VWAP70.82973 EUR
Volume (pcs)74
Trading volume5,241.40
Number of trades6
Last size1

Performance and Risk

6m1Y3Y
Perf (%)-2.83%+7.70%+31.24%
Perf (abs.)-2.07+5.08+16.92
Beta0.580.560.47
Volatility21.5324.1622.35
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)70.97 EUR (1,188)
Ø price 30 days | Ø volume 30 days (pcs.)71.18 EUR (1,395)
Ø price 100 days | Ø volume 100 days (pcs.)71.08 EUR (2,012)
Ø price 250 days | Ø volume 250 days (pcs.)74.70 EUR (4,046)
YTD High | date82.79 EUR (2023/01/09)
YTD Low | date66.92 EUR (2023/07/10)
52 Weeks High | date84.51 EUR (2022/12/13)
52 Weeks Low | date62.95 EUR (2022/10/03)

All listings for GILEAD SCIENCES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/09/2212:4770.88 EUR0.016
Vienna Stock Exchange2023/09/2209:0570.80 EUR0.001
Tradegate2023/09/2212:4170.70 EUR0.0310
Stuttgart2023/09/2208:0270.70 EUR0.001
SIX Swiss Exchange2020/04/1717:3585.00 USD0.001
SIX Swiss Exchange2022/11/0217:3679.50 CHF0.001
Nasdaq2023/09/2122:0075.27 USD398.2256,716
Munich2023/09/2208:0270.96 EUR0.001
London Stock Exchange European Trade Reporting2023/09/2209:0475.61 USD0.001
Hanover2023/09/2208:3670.72 EUR0.001
Hamburg2023/09/2208:3670.72 EUR0.001
Frankfurt2023/09/2208:0070.68 EUR0.001
Euronext Milan MTF Trading After Hours2023/09/1518:3571.72 EUR0.021
Euronext Milan MTF Global Equity Market2023/09/2117:4470.80 EUR0.001
Duesseldorf2023/09/2212:3170.66 EUR0.003
Berlin2023/09/2208:0870.70 EUR0.001
BX Swiss2023/09/2212:2968.143 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1964&ID_TYPE_IMAGE_LOGO=2

Contact Details

GILEAD SCIENCES INC.
- -
333 Lakeside Drive - 94404 Foster City
Telefon: +1-650-574-3000
Fax: +1-650-522-5853
E-mail: -

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Company Profile

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Members of Management Board

Jacqueline BartonMember of Board of Directors
Jeffrey BluestoneMember of Board of Directors
Sandra HorningMember of Board of Directors
Anthony WeltersMember of Board of Directors
Harish M. ManwaniMember of Board of Directors
Javier RodriguezMember of Board of Directors
Kelly KramerMember of Board of Directors
Kevin LoftonMember of Board of Directors
Daniel O'DayChairman of Managing Board
Adam LevyMember of Executive Committee
Flavius MartinMember of Executive Committee
Linda HigginsMember of Executive Committee
Mark ChaoMember of Executive Committee
Mark GenoveseMember of Executive Committee
Merdad ParseyMember of Executive Committee
Sarah MiksinskiMember of Executive Committee
Stacey MaMember of Executive Committee
Tomas CihlarMember of Executive Committee
William GrossmanMember of Executive Committee
Andrew DickinsonMember of Executive Committee
Cindy PerettieMember of Executive Committee
Deborah TelmanMember of Executive Committee
Dustin HainesMember of Executive Committee
Jacquie RossMember of Executive Committee
Janet DorlingMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer